BYSI BeyondSpring, Inc. - Ordinary Shares
$0,72
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 14, 2026
Rango 52S
$1–$2
3% of range
Calificación del Analista
STRONG BUY
7 analysts
Precio Objetivo
—
P/E (TTM)
—
ROE
3.1%
Margen de Beneficio Neto
—
BYSI Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.72
Capitalización Bursátil
—
P/E (TTM)
—
BPA (TTM)
—
Ingresos (TTM)
$0
Rendimiento div.
—
ROE
3.1%
Deuda/Capital
—
Rango 52S
$1 – $2
BYSI Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$0
2023-12-31
→
2025-12-31
BPA
—
Flujo de caja libre
$-20M
2024-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
BYSI
Mediana de Pares
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
BYSI
Mediana de Pares
ROA
-3.3%
-78.1%
ROE
3.1%
-228.7%
ROIC
28.1%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
BYSI
Mediana de Pares
Current Ratio (Ratio corriente)
1.5
1.2
Quick Ratio (Ratio Rápido)
0.9
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
BYSI
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
BYSI
Mediana de Pares
BYSI Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
7 analistas
- Compra fuerte 3 42,9%
- Compra 3 42,9%
- Mantener 1 14,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.03%
Próximo informe
Sep 04, 2026
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.05 | — | — |
| 31 de diciembre de 2021 | $-0.24 | $-0.27 | 0.03% |
| 30 de septiembre de 2021 | $-0.47 | $-0.38 | -0.09% |
| 30 de junio de 2021 | $-0.49 | $-0.33 | -0.16% |
| 31 de marzo de 2021 | $-0.44 | $-0.55 | 0.11% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| BYSI | — | — | — | — | 3.1% | — |
| LITS | $16M | -1.0 | 33.8% | — | -81.7% | — |
| GRML | — | — | — | — | -104.9% | — |
| QNCX | $187M | -2.0 | — | — | 700.5% | — |
| NXTC | $50M | -0.7 | — | — | -172.9% | — |
| LTRN | — | -1.9 | — | — | — | — |
| DYAI | — | -4.1 | -11.6% | — | — | — |
| KYNB | $36M | 0.2 | -78.3% | 2848.6% | -143.5% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 10
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | |
| R&D Expense | $4M | $3M | $7M | |
| SG&A Expense | $5M | $6M | $8M | |
| Operating Income | $-9M | $-9M | $-15M | |
| Interest Income | $78.0K | $59.0K | $322.0K | |
| Pretax Income | $-9M | $-9M | $-14M | |
| Income Tax | $90.0K | $96.0K | $-92.0K | |
| Net Income | $-1M | $-11M | $-21M | |
| EPS (Basic) | $-0.02 | $-0.28 | $-0.54 | |
| EBITDA | $-9M | $-9M | · |
Balance general 22
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $8M | $3M | $5M | |
| Short-term Investments | $5M | $0 | · | |
| Prepaid Expense | $71.0K | $68.0K | $168.0K | |
| Current Assets | $21M | $29M | $18M | |
| PP&E (Net) | $166.0K | $239.0K | $317.0K | |
| PP&E (Gross) | $807.0K | $793.0K | $799.0K | |
| Accum. Depreciation | $641.0K | $554.0K | $482.0K | |
| Other Non-current Assets | $224.0K | $213.0K | $123.0K | |
| Total Assets | $26M | $34M | $25M | |
| Accounts Payable | $363.0K | $295.0K | $561.0K | |
| Accrued Liabilities | $938.0K | $840.0K | $2M | |
| Current Liabilities | $14M | $11M | $8M | |
| Capital Leases | $0 | $307.0K | $589.0K | |
| Other Non-current Liabilities | $4M | $4M | $4M | |
| Total Liabilities | $50M | $49M | $48M | |
| Common Stock | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $376M | $373M | $369M | |
| Retained Earnings | $-408M | $-407M | $-396M | |
| AOCI | $602.0K | $1M | $894.0K | |
| Stockholders' Equity | $-32M | $-33M | $-27M | |
| Liabilities + Equity | $26M | $34M | $25M | |
| Shares Outstanding | 41,122,320 | 40,316,320 | 39,029,163 |
Flujo de Efectivo 11
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $722.0K | $2M | $770.0K | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-20M | $-16M | $-16M | |
| CapEx | $50.0K | $224.0K | $100.0K | |
| Investing Cash Flow | $11M | $-12M | $-100.0K | |
| Stock Issued | $2M | $3M | $0 | |
| Net Stock Activity | $2M | $3M | · | |
| Financing Cash Flow | $5M | $27M | $4.0K | |
| Net Change in Cash | $-4M | $-2M | $-17M | |
| Taxes Paid | $2.0K | $7.0K | $36.0K | |
| Free Cash Flow | $-20M | $-17M | · |
Rentabilidad 3
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -3.3% | -37.6% | · | |
| ROE | 3.1% | 37.3% | · | |
| ROIC | 28.1% | 26.3% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 1.5 | 2.6 | · | |
| Quick Ratio | 0.9 | 0.3 | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
Valoración (TTM) 6
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | |
| Net Income TTM | $-1M | $-11M | · | |
| Market Cap | · | $66M | · | |
| P/B | · | -2.0 | · | |
| P / Cash Flow | · | -4.0 | · | |
| P / FCF | · | -3.9 | · |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $973.0K | $1M | $1M | $1M | $1M | $874.0K | $472.0K | $622.0K | |
| SG&A Expense | $758.0K | $1M | $1M | $751.0K | $947.0K | $2M | $1M | $2M | |
| Operating Income | $-2M | $-2M | $-3M | $-2M | $-2M | $-3M | $-2M | $-2M | |
| Interest Income | $4.0K | $8.0K | $14.0K | $19.0K | $28.0K | $17.0K | $4.0K | $15.0K | |
| Pretax Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | |
| Income Tax | $100.0K | $192.0K | $22.0K | $26.0K | $22.0K | $20.0K | $96.0K | $0 | |
| Net Income | $-849.0K | $-2M | $-2M | $-2M | $-2M | $4M | $-2M | $-2M | |
| EPS (Basic) | $-0.02 | $-0.05 | $-0.05 | $-0.04 | $-0.04 | $0.11 | $-0.05 | $-0.05 | |
| EPS (Diluted) | · | · | · | $0.16 | $-0.10 | · | · | · | |
| Shares (Basic) | 41,119,820 | 41,119,803 | · | 40,317,266 | 40,316,320 | 40,316,320 | · | 40,300,350 | |
| EBITDA | $-2M | $-2M | · | $-2M | $-2M | $-3M | · | · |
Balance general 22
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $4M | $8M | $12M | $10M | $7M | $3M | · | |
| Short-term Investments | $4M | $4M | $5M | $141.0K | · | $2M | $0 | · | |
| Prepaid Expense | $273.0K | $181.0K | $71.0K | $131.0K | $200.0K | $90.0K | $68.0K | · | |
| Current Assets | $10M | $14M | $21M | $24M | $26M | $32M | $29M | · | |
| PP&E (Net) | $138.0K | $152.0K | $166.0K | $184.0K | $202.0K | $221.0K | $239.0K | · | |
| PP&E (Gross) | $817.0K | $812.0K | $807.0K | $803.0K | $800.0K | $796.0K | $793.0K | · | |
| Accum. Depreciation | $679.0K | $660.0K | $641.0K | $619.0K | $598.0K | $575.0K | $554.0K | · | |
| Other Non-current Assets | $128.0K | $126.0K | $224.0K | $219.0K | $216.0K | $215.0K | $213.0K | · | |
| Total Assets | $15M | $18M | $26M | $29M | $31M | $37M | $34M | · | |
| Accounts Payable | $790.0K | $646.0K | $363.0K | $304.0K | $266.0K | $358.0K | $295.0K | · | |
| Accrued Liabilities | $1M | $1M | $938.0K | $990.0K | $926.0K | $909.0K | $840.0K | · | |
| Current Liabilities | $14M | $12M | $14M | $13M | $12M | $13M | $11M | · | |
| Capital Leases | · | · | $0 | $93.0K | $170.0K | $246.0K | $307.0K | · | |
| Other Non-current Liabilities | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | |
| Total Liabilities | $51M | $49M | $50M | $49M | $49M | $50M | $49M | · | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | · | |
| Paid-in Capital | $376M | $376M | $376M | $374M | $374M | $373M | $373M | · | |
| Retained Earnings | $-411M | $-411M | $-408M | $-406M | $-405M | $-403M | $-407M | · | |
| AOCI | $55.0K | $360.0K | $602.0K | $913.0K | $1M | $1M | $1M | · | |
| Stockholders' Equity | $-36M | $-34M | $-32M | $-32M | $-30M | $-28M | $-33M | · | |
| Liabilities + Equity | $15M | $18M | $26M | $29M | $31M | $37M | $34M | · | |
| Shares Outstanding | 41,119,820 | 41,119,820 | · | 40,322,320 | 40,322,320 | 40,316,320 | 40,316,320 | · |
Flujo de Efectivo 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $575.0K | $461.0K | $167.0K | $166.0K | $145.0K | $244.0K | $399.0K | $827.0K | |
| Operating Cash Flow | $-4M | $-3M | $-6M | $-4M | $-6M | $-4M | $982.0K | $-5M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $50.0K | $27.0K | $197.0K | |
| Investing Cash Flow | $-5.0K | $4M | $-5M | $-1M | $11M | $6M | $-10M | $-2M | |
| Stock Issued | · | · | $2M | $0 | · | · | $0 | $0 | |
| Financing Cash Flow | $-74.0K | $-4M | $2M | $3M | $0 | $0 | $2M | $22M | |
| Net Change in Cash | $-4M | $-3M | $-9M | $-2M | $5M | $2M | $-7M | $15M | |
| Taxes Paid | $0 | $0 | $1.0K | $0 | $1.0K | $0 | $0 | $0 | |
| Free Cash Flow | · | $-3M | · | · | · | $-4M | · | · |
Rentabilidad 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -3.7% | -7.8% | · | -10.4% | -11.6% | 24.1% | · | · | |
| ROE | 2.6% | 6.9% | · | 9.7% | 11.9% | -31.6% | · | · | |
| ROIC | 5.2% | 7.0% | · | 5.7% | 6.5% | 9.3% | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 1.1 | · | 1.9 | 2.2 | 2.5 | · | · | |
| Quick Ratio | 0.5 | 0.6 | · | 1.0 | 0.8 | 0.7 | · | · |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · |
Valoración (TTM) 6
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | · | |
| Net Income TTM | $-6M | $-1M | · | $-1M | $-3M | $-5M | · | · | |
| Market Cap | $72M | $67M | · | $73M | $95M | $58M | · | · | |
| P/B | -2.0 | -2.0 | · | -2.3 | -3.1 | -2.0 | · | · | |
| P / Cash Flow | · | -20.6 | · | · | · | -13.8 | · | · | |
| P / FCF | · | -20.6 | · | · | · | -13.6 | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ingresos | $0 | $0 | $0 |
| Beneficio neto | $-1M | $-11M | $-21M |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio corriente | 1.5 | 2.6 | — |
| Ratio Rápido | 0.9 | 0.3 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | $-20M | $-17M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 26 declarantes · $9.4M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 8 (+3 vs trimestre anterior) | 1 (-7 vs trimestre anterior) | 3 (-1 vs trimestre anterior) | 4 (+2 vs trimestre anterior) | -2K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Decheng Capital LLC | $6 651 229 | 3 800 702 | 70,77% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 096 300 | 626 457 | 11,66% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $508 207 | 290 195 | 5,41% | Acciones |
| STATE STREET CORP | $404 460 | 231 120 | 4,30% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $317 093 | 181 196 | 3,37% | Acciones |
| BlackRock, Inc. | $158 440 | 90 537 | 1,69% | Acciones |
| NORTHERN TRUST CORP | $108 542 | 62 024 | 1,15% | Acciones |
| CITADEL ADVISORS LLC | $27 825 | 15 900 | 0,30% | Opción de compra |
| Meridian Wealth Management, LLC | $26 250 | 15 000 | 0,28% | Acciones |
| JANE STREET GROUP, LLC | $22 400 | 12 800 | 0,24% | Opción de compra |
| Farther Finance Advisors, LLC | $22 353 | 12 773 | 0,24% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $19 075 | 10 900 | 0,20% | Acciones |
| Vanguard Global Advisers, LLC | $8 404 | 4 802 | 0,09% | Acciones |
| VANGUARD GROUP INC | $7 827 | 4 802 | 0,08% | Acciones |
| MORGAN STANLEY | $7 000 | 4 000 | 0,07% | Acciones |
| NATIONAL BANK OF CANADA /FI/ | $5 031 | 2 875 | 0,05% | Acciones |
| Trifecta Capital Advisors, LLC | $2 625 | 1 500 | 0,03% | Acciones |
| Tower Research Capital LLC (TRC) | $2 566 | 1 466 | 0,03% | Acciones |
| SIMPLEX TRADING, LLC | $2 038 | 1 165 | 0,02% | Acciones |
| JPMORGAN CHASE & CO | $571 | 319 | 0,01% | Acciones |
| SBI Securities Co., Ltd. | $133 | 76 | 0,00% | Acciones |
| UBS Group AG | $100 | 57 | 0,00% | Acciones |
| TANAKA CAPITAL MANAGEMENT INC | $43 | 26 296 | 0,00% | Acciones |
| BARCLAYS PLC | $33 | 19 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $16 | 9 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $2 | 1 | 0,00% | Acciones |
Informantes de la empresa 8 insiders · 3 directivos · 6 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Min Qiu | Chief Executive Officer | 1 de julio de 2026 A | — | 0 | 0 | $0 |
| Lan Huang | Chief Executive Officer | 20 de marzo de 2026 G | 0 | 0 | 0 | $0 |
| Yingjuan June Lu | Chief Scientific Officer | 1 de abril de 2026 A | — | 0 | 0 | $0 |
| Jiangwen Majeti | Consejero | 1 de julio de 2026 A | — | 0 | 0 | $0 |
| Sihai Xu | Consejero | 1 de abril de 2026 A | — | 0 | 0 | $0 |
| Matthew Kirkby | Consejero | 1 de abril de 2026 A | — | 0 | 0 | $0 |
| Brendan Delaney | Consejero | 1 de abril de 2026 A | — | 0 | 0 | $0 |
| Patrick Fabbio | Consejero | 1 de abril de 2026 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Xiangmin Cui ×2 presentaciones | 8 de diciembre de 2020 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 3 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.